Novartis, Watson End Suit Over Enablex ANDA

Law360, New York (October 29, 2010, 4:20 PM EDT) -- Novartis Pharmaceuticals Corp. has dropped its suit against Watson Pharmaceuticals Inc. over the generic-drug maker's plans to manufacture a version of Enablex, a treatment for overactive bladder syndrome.

Judge Sue L. Robinson of the U.S. District Court for the District of Delaware on Thursday signed off on the parties' stipulated dismissal of the case without prejudice.

Details of a settlement, if any, were not revealed, and attorneys for the parties did not immediately respond to calls seeking comment Thursday.

Novartis sued Watson in April 2009, seeking...
To view the full article, register now.